戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  folding of the serotonin transporter (SERT; SLC6A4).
2 ymorphism in the serotonin transporter gene (SLC6A4).
3 GS2, two in HTR2A, one in SLC6A2, and one in SLC6A4).
4 y to ASD are PTEN and Serotonin transporter (SLC6A4).
5 terial artificial chromosome drivers Pet1 or Slc6a4.
6  variants of two functional polymorphisms of SLC6A4 (5-HTTLPR, intron 2 variable number tandem repeat
7  variants of the serotonin transporter gene (SLC6A4), a long-standing OCD candidate, have so far been
8  anxiety typically associated with the short SLC6A4 allele.
9 er region of the serotonin transporter gene (SLC6A4; also known as 5-HTT) and its contribution to str
10 ted with altered transcriptional activity of SLC6A4; an earlier study reported an association of the
11                    Analyzing four markers in SLC6A4 and four markers in ITGB3 in 117 white family tri
12        Recent major findings from studies of SLC6A4 and its corresponding protein, the serotonin (5-H
13           Messenger RNA (mRNA) expression of SLC6A4 and p11 was measured in sigmoid and rectal mucosa
14 nteraction between two markers--rs1042173 in SLC6A4 and rs3809865 in ITGB3.
15 nges in mice and rats), it seems likely that SLC6A4 and SERT will remain areas of high interest in ou
16 llustrate significant variation worldwide at SLC6A4 and that the functionally implicated alleles at t
17     Restraint stress was applied to pregnant Slc6a4 (+/+) and Slc6a4 (+/-) mice and post-stress embry
18 nsiently express the 5-HT transporter (SERT; Slc6a4) and accumulate 5-HT, suggesting that the SERT ac
19 ions between the serotonin transporter gene (SLC6A4) and alcohol, heroin, cocaine, or methamphetamine
20 er region of the serotonin transporter gene (SLC6A4) and exposure to childhood trauma.
21 er protein (SERT or soluble carrier protein, SLC6A4) and p11 (S-100A10, or calpactin I light chain).
22  variants at the serotonin transporter gene (SLC6A4) and serotonin 2A receptor gene (HTR2A) predict c
23 of interest--the serotonin transporter gene (SLC6A4) and the integrin beta 3 gene (ITGB3) on chromoso
24 en Nrxn1alpha, En2 and Fmr1; Nlgn3, BTBR and Slc6A4; and also between X monosomy and Mecp2.
25                             Polymorphisms in SLC6A4 are associated with differences in emotional, end
26 am region of the serotonin transporter gene (SLC6A4) are associated with individual differences in st
27 llection of multiple, often rare, alleles at SLC6A4 as imposing risk of autism.
28  there was no consistent association between SLC6A4*C and any Tridimensional Personality Questionnair
29 analysis revealed a positive linkage between SLC6A4*C and the 2 anxiety-related subdimensions of Harm
30     We have attempted to confirm the role of SLC6A4*C in anxiety-related personality traits by sibpai
31 association, raising the question of whether SLC6A4*C locus is itself affecting anxiety or is linked
32 sent study we replicated the relationship of SLC6A4*C to anxiety by sibpair linkage analysis but foun
33 ter of the human serotonin transporter gene (SLC6A4*C) was identified and found to be linked to an an
34                       Association studies at SLC6A4 cannot a priori extrapolate across populations an
35 membrane serotonin (5-HT) transporter (SERT, SLC6A4) clears 5-HT after release at nerve termini and i
36 escribed in the promoter region of the gene (SLC6A4) coding for the serotonin transporter protein (SE
37 hism, 5HTTLPR, in the serotonin transporter, SLC6A4, coupled with prenatal stress is reported to incr
38 of p38alpha MAPK in serotonergic neurons (by Slc6a4-Cre or ePet1-Cre) or astrocytes (by Gfap-CreERT2)
39 thy human volunteers (ADORA2A, SLC6A3, BDNF, SLC6A4, CSNK1E, SLC6A2, DRD2, FAAH, COMT, OPRM1).
40                          Embryos of stressed Slc6a4 (+/+) dams exhibited significantly altered methyl
41 ontrast, the response of embryos of stressed Slc6a4 (+/-) dams was found to be attenuated, shown by s
42 idate genes for neuropsychiatric phenotypes: SLC6A4, encoding the serotonin transporter; and SLC18A2,
43 ults contribute to a better understanding of SLC6A4 expression genetics and provide a functional hapl
44 hydroxytryptamine, 5-HT) transporter (hSERT, SLC6A4) figures prominently in the etiology and treatmen
45 nalysis supports that the association of the SLC6A4 gene with substance use disorder varies depending
46 T) transporter SERT (which is encoded by the SLC6A4 gene) to platelet 5-HT stores suggests an importa
47 point to a more complex relationship between SLC6A4 genotype and protein availability.
48                       There was no effect of SLC6A4 genotype upon serotonin transporter binding.
49              The serotonin transporter (SERT/SLC6A4) has a rich pharmacology including inhibitors, re
50 ion of the human serotonin transporter gene (SLC6A4) has been associated with several dimensions of n
51                   The serotonin transporter (SLC6A4) has been associated with several stress-related
52            The 5-HT transporter (SERT) gene (SLC6A4) has been associated with whole blood 5-HT levels
53 er region of the serotonin transporter gene (SLC6A4) has been found to moderate several categories of
54  promoter of the serotonin transporter gene (SLC6A4) has been proposed as a pharmacogenetic marker fo
55 Variation at the serotonin transporter gene, SLC6A4, has been associated with a variety of neuropsych
56 rotonin (5-HT) transporter (SERT, encoded by SLC6A4) have been identified in ASD.
57 e found normal colonic mucosal expression of SLC6A4 in diarrhea (IBS-D)- or constipation-predominant
58                Colonic mucosal expression of SLC6A4 in IBS is normal.
59 ssion and activity of 5-HT Transporter (SERT/Slc6a4) in 5-HT neurons leading to an increase of 5-HT u
60 he serotonin (5-HT) transporter gene (5-HTT, SLC6A4) in modulating amygdala and prefrontal activation
61             The serotonin transporter (SERT, SLC6A4) in the platelet plasma membrane represents a wel
62 amine (5-HT)] transporters (hSERT, 5HTT, and SLC6A4) inactivate 5-HT after release and are prominent
63 lymorphism of the serotonin transporter gene SLC6A4, influences cerebral cortical structure volumes i
64              The serotonin transporter gene (SLC6A4) is a strong autism candidate gene because of its
65 , including the human serotonin transporter (SLC6A4), is critical for efficient synaptic transmission
66 er region of the serotonin transporter gene (SLC6A4), is implicated in speech encoding in the human s
67                          Similarly, maternal Slc6a4 knock-out and prenatal stress in rodents results
68              Combining these HTR3A/HTR3B and SLC6A4-LL/TT genotypes increased the target cohort from
69 B in the same sample that they genotyped for SLC6A4-LL/TT in the previous randomized, double-blind, 1
70 rted that the 5'-HTTLPR-LL and rs1042173-TT (SLC6A4-LL/TT) genotypes in the serotonin transporter gen
71 nvestigate the role of additional functional SLC6A4 loci in OCD.
72                                          The SLC6A4 locus encodes the serotonin transporter, which in
73 pothesis that the S allele of 5HTTLPR at the SLC6A4 locus is associated with a poor outcome after tre
74 umber of genes including SLC6A3, DRD5, DRD4, SLC6A4, LPHN3, SNAP-25, HTR1B, NOS1 and GIT1.
75 ess was applied to pregnant Slc6a4 (+/+) and Slc6a4 (+/-) mice and post-stress embryonic brains were
76  this phenotype is exacerbated in Pten(+/-); Slc6a4(+/-) mice.
77 ype that is exacerbated in female Pten(+/-); Slc6a4(+/-) mice.
78 ions of the DR, there were no differences in slc6a4 mRNA expression between MS15 and AFR rats.
79 ubsequent exposure to adult social defeat on slc6a4 mRNA expression in the dorsal raphe nucleus (DR)
80 sed to social defeat as adults had increased slc6a4 mRNA expression throughout the DR compared to bot
81 to a novel cage control condition, increased slc6a4 mRNA expression was observed in the dorsal part o
82                      Social defeat increased slc6a4 mRNA expression, but only in MS180 rats and only
83 ience during adulthood interact to determine slc6a4 mRNA expression.
84 ween these factors on serotonin transporter (slc6a4) mRNA expression, we investigated in rats the eff
85 human primates indicate that combinations of SLC6A4 non-coding 5', 3' UTRs and intronic regions plus
86 ne promotor polymorphism (5-HTTLPR) locus of SLC6A4 now exist.
87 R and CYP1A2) and pharmacodynamics (BDNF and SLC6A4) of caffeine.
88   In Necdin-KO pups, the genetic deletion of Slc6a4 or treatment with Fluoxetine, a 5-HT reuptake inh
89 on serotonin (5-HT) transporter (5-HTT/SERT, SLC6A4) polymorphism is believed to confer lower 5-HTT e
90 gical mechanisms underlying the link between SLC6A4 polymorphisms and the emotionally vulnerable phen
91                                              SLC6A4 polymorphisms STin2, 5-HTTLPR, and rs25531 were g
92  influenced ability to detect association of SLC6A4 polymorphisms with personality measures; populati
93              We first sequenced the marmoset SLC6A4 promoter and identified a double nucleotide polym
94 rry a specific stress responsiveness-related SLC6A4 promoter genotype.
95                                          The SLC6A4 promoter polymorphism 5-HTTLPR influences cerebra
96        The authors assessed genotypes at the SLC6A4 promoter polymorphism in 96 healthy European Amer
97                They assessed genotype at the SLC6A4 promoter polymorphism, and an additional polymorp
98 , serotonin], member 4) gene, as well as the SLC6A4 promoter region polymorphism, 5-HTTLPR.
99 ociation between the serotonin protein gene (SLC6A4) promoter variant (5-HTTLPR) and risk of current
100 ansmitter transporter, serotonin), member 4 (SLC6A4), promoter, affects transcription and may be invo
101 sm and serotonin transporter genotype at the SLC6A4 promotor VNTR polymorphism in 30 healthy subjects
102 PR) in the human serotonin transporter gene (SLC6A4), resulting in altered transcription and transpor
103 synaptosomal-associated protein, 25 kDa) and SLC6A4 (serotonin transporter).
104 ter (SLC6A2, NET) and serotonin transporter (SLC6A4, SERT) genes and remission in depressed older adu
105 sopressin receptor 1a) gene and STin2 in the SLC6A4 (solute carrier family 6 [neurotransmitter transp
106  17q11.2 region that harbors the SERT locus (SLC6A4) supports a genetic effect at or near this gene.
107 ed copy of the 5-HT transporter (i.e., SERT, slc6a4) that bears a single amino acid substitution, I17
108 cleotide polymorphisms (SNPs) for AVPR1A and SLC6A4 to determine whether other variants in these gene
109 location of the serotonin transporter (SERT, SLC6A4) to the synaptic terminals of serotonergic neuron
110 P1, GABRB2, GRIN2B, HP, IL1B, MTHFR, PLXNA2, SLC6A4, TP53 and TPH1) showed nominally significant effe
111    Because the L(A) allele confers increased SLC6A4 transcription, increased serotonin transporter le
112 sm in the serotonin transporter gene (locus, SLC6A4; variant, serotonin 5-HTTLPR) moderates risk of p
113                                     In vivo, SLC6A4 variants in humans and other species lead to mark
114 32 and all other known non-coding functional SLC6A4 variants revealed a highly significant omnibus as
115                 Genotype of the promoter for SLC6A4 was also assessed in all participants.
116      To determine the extent of variation at SLC6A4, we genotyped 23 markers on approximately 2500 in

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top